MyAverix Finance
US · Healthcare
Immunitybio Inc (IBRX)
Biotechnology
Immunitybio Inc (IBRX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $7.56B, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for IBRX
Immunitybio Inc (IBRX) — FAQ
What is Immunitybio Inc's market cap?
Immunitybio Inc (IBRX) has a reported market cap of $7.56B (data as of 2026-05-24).
What is IBRX's P/E ratio?
The price-to-earnings (P/E) ratio for Immunitybio Inc (IBRX) is 25.00 (data as of 2026-05-24).
Does Immunitybio Inc pay a dividend?
Dividend yield is not available in the current snapshot for Immunitybio Inc (IBRX). Check the MyAverix Finance app for the latest dividend data.
What sector is Immunitybio Inc in?
Immunitybio Inc (IBRX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is IBRX listed on?
IBRX is listed on US.
What is Immunitybio Inc's net margin?
Immunitybio Inc (IBRX) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.